Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page
- CheckyesterdayChange DetectedA minor revision label was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUI glossary visibility options were added (Show glossary / Hide glossary). New metadata entries were introduced: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page shows an update of the revision tag from v3.3.3 to v3.3.4, with no visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedLocations section updated with a broad set of new site entries and regional designations (e.g., Bayonne Cedex, Pays de la Loire Region, Slovak Republic, Balearic Islands, Basque Country, Catalonia, Madrid, Santa Cruz De Tenerife, etc.), and several former location groupings were removed.SummaryDifference2%

- Check72 days agoChange DetectedA note now states that publications are automatically filled from PubMed and may not all pertain to the study; the revision has been updated to v3.3.2 (from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedDeletion of the government funding/status notice from the page; the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.